Zobrazeno 1 - 10
of 38
pro vyhledávání: '"J H, Finke"'
Publikováno v:
Methods in molecular medicine. 53
Functional T cells are the central component of an effective antitumor immune response. However, in patients with renal cell carcinoma (RCC), the growth of antigenic tumors proceeds in the absence of significant T-cell responses, posing a distinct ob
Publikováno v:
The Journal of Immunology. 149:529-534
The combination of IFN-gamma and IL-2 has been demonstrated to induce or promote transcription from selected inflammatory cytokine genes in both monocytes and macrophages. In the present report, we have evaluated the ability of these agents to activa
Autor:
P A, Cohen, L, Peng, J, Kjaergaard, G E, Plautz, J H, Finke, G K, Koski, B J, Czerniecki, S, Shu
Publikováno v:
Critical reviews in immunology. 21(1-3)
The T cells of many cancer patients are naturally sensitized to tumor-associated antigens (Ag), or they can readily be sensitized with vaccine maneuvers. In melanoma patients, the adoptive transfer of such T cells can often be causally linked to the
Autor:
R G, Uzzo, V, Kolenko, C J, Froelich, C, Tannenbaum, L, Molto, A C, Novick, N H, Bander, R, Bukowski, J H, Finke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(10)
The antitumor effect of T cells is executed either through CD95 or Perforin (PFN)/Granzyme B (GrB) pathways. Induction of apoptosis by either mode requires activation of caspase family members. However, recent studies have suggested that cell death c
Publikováno v:
Apoptosis : an international journal on programmed cell death. 6(6)
Alterations in intracellular Zn(2+) concentrations are believed to play a crucial role in modulating apoptosis. The observation that Zn(2+) deficiency can induce cell death both in vivo and in vitro has been attributed to the fact that exchange of Zn
Autor:
J H, Finke, P, Rayman, R, George, C S, Tannenbaum, V, Kolenko, R, Uzzo, A C, Novick, R M, Bukowski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Antitumor immunity fails to adequately develop in many cancer patients, including those with renal cell carcinoma (RCC). A number of different mechanisms have been proposed to explain the immune dysfunction observed in cancer patient T cells. Here we
Publikováno v:
Apoptosis : an international journal on programmed cell death. 5(1)
The majority of current anticancer therapies induce tumor cell death through the induction of apoptosis. Alterations in the apoptotic pathways may determine tumor resistance to these therapies. Activation of the proteolytic cascade involving caspase
Autor:
P, Rayman, R G, Uzzo, V, Kolenko, T, Bloom, M K, Cathcart, L, Molto, A C, Novick, R M, Bukowski, T, Hamilton, J H, Finke
Publikováno v:
The cancer journal from Scientific American. 6
The development of an effective antitumor immune response is compromised in patients with renal cell carcinoma. Despite significant infiltration by T lymphocytes into renal tumors, no detectable induction of gene expression is associated with the gen
Autor:
R G, Uzzo, P, Rayman, V, Kolenko, P E, Clark, T, Bloom, A M, Ward, L, Molto, C, Tannenbaum, L J, Worford, R, Bukowski, R, Tubbs, E D, Hsi, N H, Bander, A C, Novick, J H, Finke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(5)
Tumors may escape immune recognition and destruction through the induction of apoptosis in activated T lymphocytes. Results from several laboratories suggest that FasL (L/CD95L) expression in tumors may be responsible for this process. In this study
Autor:
R M, Bukowski, P, Rayman, R, Uzzo, T, Bloom, K, Sandstrom, D, Peereboom, T, Olencki, G T, Budd, D, McLain, P, Elson, A, Novick, J H, Finke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(10)
Studies have demonstrated abnormalities of the CD3/T-cell antigen receptor (TCR) and pathways of signal transduction in T lymphocytes from animals and patients with advanced malignancy. Diminished expression of TCRzeta and p56(lck) that are associate